drugset / Trial / NCT00016445

Phase II Study of Growth Hormone in Children With Cystic Fibrosis

NCT00016445

Phase 2 Completed 40 enrolled University of Utah
Treatment

Summary

OBJECTIVES: I. Determine the effect of growth hormone on height, height velocity, body weight, and lean body mass in patients with cystic fibrosis. II. Determine the effect of growth hormone on pulmonary function in these patients. III. Determine the impact of this drug on the quality of life in these patients. IV. Determine if the clinical response from this drug is sustained in these patients.

Timeline

Start
2001-02
Primary completion
2007-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic Subcutaneous

Indications